Schedule 13G Amendment No. 1

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AeltAqR4N1R+a71Qy/v3P5qe9EWG1WxzWqb5032DSdXA68AiyAIOZF5cGclcpboV dpmc7K1/jn0BDkWqhXawWg== 0001193125-07-024920.txt : 20070209 0001193125-07-024920.hdr.sgml : 20070209 20070209073221 ACCESSION NUMBER: 0001193125-07-024920 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20070209 DATE AS OF CHANGE: 20070209 GROUP MEMBERS: CHENGXUAN INTERNATIONAL LTD. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: China Medical Technologies, Inc. CENTRAL INDEX KEY: 0001326059 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81526 FILM NUMBER: 07595427 BUSINESS ADDRESS: STREET 1: NO.24 YONG CHANG NORTH ROAD STREET 2: BEIJING ECONOMIC-TECHNOLOGICAL CITY: DEVELOPMENT AREA, BEIJING STATE: F4 ZIP: 100176 BUSINESS PHONE: (86-10) 6787 1166 MAIL ADDRESS: STREET 1: NO.24 YONG CHANG NORTH ROAD STREET 2: BEIJING ECONOMIC-TECHNOLOGICAL CITY: DEVELOPMENT AREA, BEIJING STATE: F4 ZIP: 100176 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Wu Xiaodong CENTRAL INDEX KEY: 0001354070 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 8610-6787-1166 MAIL ADDRESS: STREET 1: NO. 24 YONG CHANG NORTH ROAD STREET 2: BEIJING ECONOMIC-TECHNOLOGICAL DEV AREA CITY: BEIJING 100176 STATE: F4 ZIP: - SC 13G/A 1 dsc13ga.htm SCHEDULE 13G AMENDMENT NO. 1 Schedule 13G Amendment No. 1

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

RULES 13d-1(b), (c)

AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

(Amendment No. 1)*

China Medical Technologies, Inc.

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)

169483104

(CUSIP Number)

December 31, 2006

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CU No. 169483104				2


1.		NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

		Mr. Xiaodong Wu
2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
		(a) x
		(b) ¨
3.		SEC USE ONLY

4.		CITIZENSHIP OR PLACE OF ORGANIZATION

		The People’s Republic of China


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5. SOLE VOTING POWER

		0
		6. SHARED VOTING POWER

		71,420,001
		7. SOLE DISPOSITIVE POWER

		0
		8. SHARED DISPOSITIVE POWER

		71,420,001


9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	71,420,001 ordinary shares held in the name of Chengxuan International Ltd., a British Virgin Islands company and a reporting person listed on the next page of this statement on Schedule 13G. Mr. Xiaodong Wu is the sole beneficial owner of Chengxuan International Ltd.
10.	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)	¨

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	26.1%
12.	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

	IN


CU No. 169483104				3


1.		NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

		Chengxuan International Ltd.
2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
		(a) x
		(b) ¨
3.		SEC USE ONLY

4.		CITIZENSHIP OR PLACE OF ORGANIZATION

		British Virgin Islands


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5. SOLE VOTING POWER

		0
		6. SHARED VOTING POWER

		71,420,001
		7. SOLE DISPOSITIVE POWER

		0
		8. SHARED DISPOSITIVE POWER

		71,420,001


9.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	71,420,001 ordinary shares held in the name of Chengxuan International Ltd. Mr. Xiaodong Wu is the sole beneficial owner of Chengxuan International Ltd.
10.	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)	¨

11.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

	26.1%
12.	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

	CO


				4

Item 1

(a).

NAME OF ISSUER:

This statement relates to the Ordinary Shares (the “Ordinary Shares”) of the issuer, China Medical Technologies, Inc., a Cayman Islands company (the “Company”).

Item 1

(b).

ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

The principal executive offices of the Company are located at No. 24 Yong Chang North Road, Beijing Economic-Technological Development Area, Beijing 100176, People’s Republic of China.

Item 2

(a).

NAME OF PERSON FILING:

Xiaodong Wu

Chengxuan International Ltd.

Item 2

(b).

ADDRESS OF PRINCIPAL BUSINESS OFFICE:

The address of the principal business office of Xiaodong Wu and Chengxuan International Ltd. is c/o China Medical Technologies, Inc., No. 24 Yong Chang North Road, Beijing Economic-Technological Development Area, Beijing 100176, People’s Republic of China.

Item 2

(c).

CITIZENSHIP:

Xiaodong Wu is a citizen of The People’s Republic of China. The place of organization for Chengxuan International Ltd. is the British Virgin Islands

Item 2

(d).

TITLE OF CLASS OF SECURITIES:

Ordinary Shares.

Item 2

(e).

CUSIP NUMBER:

169483104

Item 3.

IF THIS STATEMENT IS FILED PURSUANT TO §§240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:

Not applicable.


				5


Item 4.	OWNERSHIP:

	The following information with respect to the ownership of the Ordinary Shares of the Company by the persons filing this statement is provided as of January 31, 2007. The percentage amounts are based on 273,600,001 Ordinary Shares outstanding as of January 31, 2007, as derived from the Company’s corporate records.

	Because Mr. Xiaodong Wu is the sole beneficial owner of Chengxuan International Ltd., Mr. Xiaodong Wu may be deemed to control Chengxuan International Ltd. and share voting and dispositive power with Chengxuan International Ltd. over such Ordinary Shares of the Company held by it.

	For Mr. Xiaodong Wu

	(a)	Amount beneficially owned: 71,420,001

	(b)	Percent of class: 26.1%

	(c)	Number of shares as to which such person has:

		i.	sole power to vote or to direct the vote: 0

		ii.	shared power to vote or to direct the vote: 71,420,001

		iii.	sole power to dispose or to direct the disposition: 0

		iv.	shared power to dispose or to direct the disposition: 71,420,001

	For Chengxuan International Ltd.

	(a)	Amount beneficially owned: 71,420,001

	(b)	Percent of class: 26.1%

	(c)	Number of shares as to which such person has:

		i.	sole power to vote or to direct the vote: 0

		ii.	shared power to vote or to direct the vote: 71,420,001

		iii.	sole power to dispose or to direct the disposition: 0

		iv.	shared power to dispose or to direct the disposition: 71,420,001

Item 5.	OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

	Not applicable.

Item 6.	OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

	Not applicable.

Item 7.	IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

	Not applicable.

Item 8.	IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

	Not applicable.

Item 9.	NOTICE OF DISSOLUTION OF GROUP

	Not applicable.

Item 10.	CERTIFICATION

	Not applicable.


				6

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Dated: February 9, 2007

		/s/ Xiaodong Wu
Name:		Mr. Xiaodong Wu


Chengxuan International Ltd.

By:		/s/ Xiaodong Wu
Name:		Mr. Xiaodong Wu
Title:		Sole Beneficial Owner and Director

EX-99.(A) 2 dex99a.htm JOINT FILING AGREEMENT Joint Filing Agreement

EXHIBIT A

Joint Filing Agreement

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary shares, par value $0.10 per share, of China Medical Technologies, Inc., a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

[Remainder of this page has been left intentionally blank.]

SIGNATURES

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of the 9th day of February 2007.


		/s/ Xiaodong Wu
Name:		Mr. Xiaodong Wu


Chengxuan International Ltd.

By:		/s/ Xiaodong Wu
Name:		Mr. Xiaodong Wu
Title:		Sole Beneficial Owner and Director

-----END PRIVACY-ENHANCED MESSAGE-----